Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884966151> ?p ?o ?g. }
- W2884966151 endingPage "1803" @default.
- W2884966151 startingPage "1803" @default.
- W2884966151 abstract "Chalcones have shown a broad spectrum of biological activities with clinical potential against various diseases. The biological activities are mainly attributed to the presence in the chalcones of the α,β-unsaturated carbonyl system, perceived as a potential Michael acceptor. Chalcones could activate the Kelch-like ECH-associated protein 1 (Keap1)/Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway through a Michael addition reaction with the cysteines of Keap1, which acts as a redox sensor and negative regulator of Nrf2. This modification allows the dissociation of Nrf2 from the cytoplasmic complex with Keap1 and its nuclear translocation. At this level, Nrf2 binds to the antioxidant response element (ARE) and activates the expression of several detoxification, antioxidant and anti-inflammatory genes as well as genes involved in the clearance of damaged proteins. In this regard, the Keap1/Nrf2–ARE pathway is a new potential pharmacological target for the treatment of many chronic diseases. In this review we summarize the current progress in the study of Keap1/Nrf2–ARE pathway activation by natural and synthetic chalcones and their potential pharmacological applications. Among the pharmacological activities highlighted, anti-inflammatory activity was more evident than others, suggesting a multi-target Michael acceptor mechanism for the chalcones involving key regulators of the Nrf2 and nuclear factor- κB (NF-κB) pathways." @default.
- W2884966151 created "2018-08-03" @default.
- W2884966151 creator A5008452131 @default.
- W2884966151 creator A5021455433 @default.
- W2884966151 creator A5032908630 @default.
- W2884966151 creator A5040070958 @default.
- W2884966151 creator A5060402578 @default.
- W2884966151 creator A5068062350 @default.
- W2884966151 creator A5080065374 @default.
- W2884966151 date "2018-07-20" @default.
- W2884966151 modified "2023-10-16" @default.
- W2884966151 title "The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones" @default.
- W2884966151 cites W1142141257 @default.
- W2884966151 cites W1560196283 @default.
- W2884966151 cites W1893923004 @default.
- W2884966151 cites W1965767470 @default.
- W2884966151 cites W1970959987 @default.
- W2884966151 cites W1972039645 @default.
- W2884966151 cites W1985638952 @default.
- W2884966151 cites W1993123663 @default.
- W2884966151 cites W1997887886 @default.
- W2884966151 cites W1999148207 @default.
- W2884966151 cites W2001317331 @default.
- W2884966151 cites W2002977651 @default.
- W2884966151 cites W2003514167 @default.
- W2884966151 cites W2009278160 @default.
- W2884966151 cites W2010838405 @default.
- W2884966151 cites W2020001496 @default.
- W2884966151 cites W2026950982 @default.
- W2884966151 cites W2034968362 @default.
- W2884966151 cites W2035329867 @default.
- W2884966151 cites W2039543356 @default.
- W2884966151 cites W2044280032 @default.
- W2884966151 cites W2048883883 @default.
- W2884966151 cites W2058703792 @default.
- W2884966151 cites W2068102724 @default.
- W2884966151 cites W2072618076 @default.
- W2884966151 cites W2083670406 @default.
- W2884966151 cites W2084810520 @default.
- W2884966151 cites W2087199535 @default.
- W2884966151 cites W2114744780 @default.
- W2884966151 cites W2120505276 @default.
- W2884966151 cites W2133584350 @default.
- W2884966151 cites W2136466556 @default.
- W2884966151 cites W2171450309 @default.
- W2884966151 cites W2207351430 @default.
- W2884966151 cites W2214258829 @default.
- W2884966151 cites W2256563521 @default.
- W2884966151 cites W2259960193 @default.
- W2884966151 cites W2266077892 @default.
- W2884966151 cites W2294865233 @default.
- W2884966151 cites W2339123395 @default.
- W2884966151 cites W2340599578 @default.
- W2884966151 cites W2347236137 @default.
- W2884966151 cites W2398775408 @default.
- W2884966151 cites W2401030213 @default.
- W2884966151 cites W2468224385 @default.
- W2884966151 cites W2477594648 @default.
- W2884966151 cites W2537898560 @default.
- W2884966151 cites W2559760121 @default.
- W2884966151 cites W2588514054 @default.
- W2884966151 cites W2591069557 @default.
- W2884966151 cites W2608211496 @default.
- W2884966151 cites W2611689827 @default.
- W2884966151 cites W2612945947 @default.
- W2884966151 cites W2613820968 @default.
- W2884966151 cites W2617360484 @default.
- W2884966151 cites W2625710117 @default.
- W2884966151 cites W2736732523 @default.
- W2884966151 cites W2765786596 @default.
- W2884966151 cites W2770410202 @default.
- W2884966151 cites W2773072411 @default.
- W2884966151 cites W2783026016 @default.
- W2884966151 cites W2790475021 @default.
- W2884966151 cites W2799290037 @default.
- W2884966151 cites W3207905482 @default.
- W2884966151 cites W322867983 @default.
- W2884966151 cites W361456583 @default.
- W2884966151 cites W840875033 @default.
- W2884966151 doi "https://doi.org/10.3390/molecules23071803" @default.
- W2884966151 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6100069" @default.
- W2884966151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30037040" @default.
- W2884966151 hasPublicationYear "2018" @default.
- W2884966151 type Work @default.
- W2884966151 sameAs 2884966151 @default.
- W2884966151 citedByCount "69" @default.
- W2884966151 countsByYear W28849661512019 @default.
- W2884966151 countsByYear W28849661512020 @default.
- W2884966151 countsByYear W28849661512021 @default.
- W2884966151 countsByYear W28849661512022 @default.
- W2884966151 countsByYear W28849661512023 @default.
- W2884966151 crossrefType "journal-article" @default.
- W2884966151 hasAuthorship W2884966151A5008452131 @default.
- W2884966151 hasAuthorship W2884966151A5021455433 @default.
- W2884966151 hasAuthorship W2884966151A5032908630 @default.
- W2884966151 hasAuthorship W2884966151A5040070958 @default.
- W2884966151 hasAuthorship W2884966151A5060402578 @default.
- W2884966151 hasAuthorship W2884966151A5068062350 @default.